Bryan T. Richardson Ph.D.
Patent Agent

“When I write a patent, I look ahead and envision what it will need to withstand a team of lawyers trying to attack it from any and all angles in the future.”

Dr. Bryan Richardson is a scientific advisor and patent agent working in the biotech, medical, biochemical, and pharmaceutical arts. He focuses his practice on patent preparation and prosecution for small molecules, pharmaceutical formulations, diagnostic technology, and medical devices. Bryan also advises clients preparing for inter partes review proceedings before the Patent Trial and Appeal Board. He regularly conducts patentability searches, freedom-to-operate studies for clients, and provides patent portfolio valuation for mergers and acquisition as well as joint development and licensing agreements.  He represents a broad range of clients, including both generic and branded pharmaceutical companies, universities, and start-ups.  

Prior to working for Brinks Gilson and Lione, Bryan earned his doctorate degree from the Department of Pharmacology at the University of North Carolina. His research involved the study of the faulty Rho GTPase signaling mechanisms underlying the cerebrovascular disorder cerebral cavernous malformation (CCM) by using a broad range of cutting edge biotechnology techniques. His research further generated new induced pluripotent stem cell based methods for modeling this disease in cells from human patients affected by CCM.  

This advanced technical background gives him unique insights not only into the science behind his clients’ products, but also how to best protect their valuable innovations. Bryan’s goal is to partner with his clients to develop the most useful patent strategy early on that will secure robust patents, which will withstand litigation, post-grant review, and any other challenges.

  • Ph.D., Pharmacology
    University of North Carolina at Chapel Hill
Bar Admissions
  • U.S. Patent & Trademark Office
Experience | Overview
  • Prosecuted diverse portfolios of patents and secured allowances in cases stalled with difficult prior art issues
  • Prosecuted recent diagnostic patent applications with difficult natural correlation rejection issues stemming from recent Supreme Court holdings
  • Performed patent portfolio due diligence and freedom to operate studies for a diagnostic company prior to the successful acquisition of several smaller companies
  • Represented a generic company in an inter partes review proceeding
Experience | Non-Legal
University of North Carolina at Chapel Hill
Carolina KickStart (eTeams) Trainee, 2013-2014
Forward Thinking
September 03, 2015
Press Releases & Events
September 02, 2015
RESEARCH TRIANGLE PARK, N.C.— Brinks Gilson & Lione, one of the nation’s largest intellectual property law firms, today announced that four attorneys and one patent agent are joining its life sciences group in Research Triangle Park, ...
  • Triangle Intellectual Property Law Association